Back |
home / stock / lnth / lnth message board
Subject | By | Source | When |
---|---|---|---|
You have any intel that you could share | SmileyRiley_595 | investorshub | 08/23/2020 5:09:50 AM |
Im thinking I might like that... | SmileyRiley_595 | investorshub | 08/23/2020 5:09:12 AM |
You realize that there is no moderator for | Chuckles759 | investorshub | 08/23/2020 5:07:16 AM |
The $5.95 was for the white elephant gift | SmileyRiley_595 | investorshub | 08/23/2020 5:05:15 AM |
Smiley, I've been attempting to tweak my $CYDY/LNTH revenue | Chuckles759 | investorshub | 08/23/2020 4:59:35 AM |
Ok... I guess I really need to start | SmileyRiley_595 | investorshub | 08/23/2020 2:46:04 AM |
First time I have been on the$ LNTH | Black-Ops | investorshub | 08/23/2020 1:36:06 AM |
Tempting....but I'm about to engage moving homes three | Chuckles759 | investorshub | 08/11/2020 11:42:01 PM |
I requested to be a mod. join me. | BobTheChiro | investorshub | 08/11/2020 8:26:18 PM |
Hello BobTheChiro !! | Chuckles759 | investorshub | 08/11/2020 8:24:25 PM |
I see I wasn't the only one looking | BobTheChiro | investorshub | 08/11/2020 8:15:36 PM |
Looks like $LNTH is awakening. | Chuckles759 | investorshub | 08/10/2020 9:28:52 PM |
News, Short Squeeze, Breakout and More Instantly...
Lantheus Holdings Inc. Company Name:
LNTH Stock Symbol:
NASDAQ Market:
Lantheus Holdings Inc. Website:
BEDFORD, Mass., June 27, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced its acqu...
Lantheus has agreed to make an initial strategic equity investment of A$7.5 million in Radiopharm Offer price for the shares of A$0.05 represents a 47% premium to the last closing price of $0.034 on 19 June 2024 Option for Lantheus to invest a further A$7.5m within 6 months on the same ...
BEDFORD, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced that aPROMISE...